{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:57:30Z","timestamp":1784901450895,"version":"3.55.0"},"reference-count":50,"publisher":"The Endocrine Society","issue":"3","funder":[{"DOI":"10.13039\/100010629","name":"Fulbright Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010629","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["2013T083"],"award-info":[{"award-number":["2013T083"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["2013T083"],"award-info":[{"award-number":["2013T083"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Women with polycystic ovary syndrome (PCOS) are at increased risk for obstetric and perinatal complications. At present, it is unknown how characteristics of PCOS relate to the likelihood of these complications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate which preconception features are associated with obstetric and perinatal disease among infertile women with PCOS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Data from two prospective cohort studies completed from January 2004 until January 2014 were linked to Dutch Perinatal national registry outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Two Dutch university medical centers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>2768 women diagnosed with PCOS were included. Participants underwent an extensive standardized preconception screening. Exclusion criteria included: age &amp;lt;18 years or &amp;gt;45 years, language barrier, or failure to meet PCOS criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Interventions<\/jats:title>\n                  <jats:p>None.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Outcome measures were obtained from the Dutch Perinatal national registry and included: preeclampsia, preterm delivery, small for gestational age (SGA), low Apgar score, and any adverse outcome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>1715 (62% of participants) women with PCOS were identified as undergoing a pregnancy with live birth after screening. In fully adjusted models, prepregnancy free androgen index was associated with subsequent preeclampsia [OR (95% CI), 1.1 (1.0 to 1.1)]. Fasting glucose [1.4 (1.2 to 1.7)] and testosterone [1.5 (1.2 to 1.7)] predicted preterm delivery. Fasting insulin [1.003 (1.001 to 1.005)], and testosterone [1.2 (1.1 to 1.4)] predicted any adverse outcome. SGA was only predicted by features nonspecific to PCOS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Primary disease characteristics of PCOS, chiefly hyperandrogenism and impaired glucose tolerance, predict suboptimal obstetric and neonatal outcomes. Increased surveillance during pregnancy should focus on women with PCOS and these features to help mitigate disease risk.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2018-01787","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T19:09:50Z","timestamp":1545678590000},"page":"809-818","source":"Crossref","is-referenced-by-count":52,"title":["Pre-Conception Characteristics Predict Obstetrical and Neonatal Outcomes in Women With Polycystic Ovary Syndrome"],"prefix":"10.1210","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6250-6942","authenticated-orcid":false,"given":"Jacob P","family":"Christ","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine & Gynecology, University Medical Center Utrecht, Utrecht, Netherlands"},{"name":"Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlise N","family":"Gunning","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine & Gynecology, University Medical Center Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Meun","sequence":"additional","affiliation":[{"name":"Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, Erasmus University Medical Centre, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinus J C","family":"Eijkemans","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine & Gynecology, University Medical Center Utrecht, Utrecht, Netherlands"},{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas B","family":"van Rijn","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, University Medical Center Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gouke J","family":"Bonsel","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, University Medical Center Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop S E","family":"Laven","sequence":"additional","affiliation":[{"name":"Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, Erasmus University Medical Centre, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C J M","family":"Fauser","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine & Gynecology, University Medical Center Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,12,24]]},"reference":[{"issue":"1","key":"2020071623083447000_B1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"issue":"1","key":"2020071623083447000_B2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"issue":"1","key":"2020071623083447000_B3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","journal-title":"Hum Reprod"},{"issue":"4","key":"2020071623083447000_B4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"issue":"3","key":"2020071623083447000_B5","doi-asserted-by":"crossref","first-page":"1073-9.e1","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: Systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"issue":"6","key":"2020071623083447000_B6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"issue":"3","key":"2020071623083447000_B7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tem.2014.12.003","article-title":"Metabolic risk in PCOS: phenotype and adiposity impact","volume":"26","author":"Moran","year":"2015","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"2020071623083447000_B8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum Reprod Update"},{"issue":"6","key":"2020071623083447000_B9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"issue":"6","key":"2020071623083447000_B10","doi-asserted-by":"crossref","first-page":"558.e1","DOI":"10.1016\/j.ajog.2011.03.021","article-title":"Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis","volume":"204","author":"Kjerulff","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2020071623083447000_B11","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/AOG.0000000000000852","article-title":"Implications of polycystic ovary syndrome for pregnancy and for the health of offspring","volume":"125","author":"Doherty","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"51","key":"2020071623083447000_B12","doi-asserted-by":"crossref","first-page":"e4863","DOI":"10.1097\/MD.0000000000004863","article-title":"Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2020071623083447000_B13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5653\/cerm.2011.38.2.103","article-title":"Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study","volume":"38","author":"Han","year":"2011","journal-title":"Clin Exp Reprod Med"},{"key":"2020071623083447000_B14","doi-asserted-by":"crossref","first-page":"d6309","DOI":"10.1136\/bmj.d6309","article-title":"Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study","volume":"343","author":"Roos","year":"2011","journal-title":"BMJ"},{"issue":"5","key":"2020071623083447000_B15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/1471-0528.12558","article-title":"Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia","volume":"121","author":"Naver","year":"2014","journal-title":"BJOG"},{"key":"2020071623083447000_B16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-7827-11-56","article-title":"Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"11","author":"Qin","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"issue":"5","key":"2020071623083447000_B17","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.fertnstert.2009.10.043","article-title":"Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes","volume":"94","author":"Palomba","year":"2010","journal-title":"Fertil Steril"},{"issue":"6673","key":"2020071623083447000_B18","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/bmj.298.6673.564","article-title":"Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease","volume":"298","author":"Barker","year":"1989","journal-title":"BMJ"},{"issue":"5","key":"2020071623083447000_B19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S2040174415001324","article-title":"The \u2018Developmental Origins\u2019 Hypothesis: relevance to the obstetrician and gynecologist","volume":"6","author":"Kermack","year":"2015","journal-title":"J Dev Orig Health Dis"},{"issue":"6","key":"2020071623083447000_B20","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/humrep\/deu077","article-title":"Preconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndrome","volume":"29","author":"de Wilde","year":"2014","journal-title":"Hum Reprod"},{"key":"2020071623083447000_B21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.steroids.2014.06.005","article-title":"Lipid profile in nonobese pregnant women with polycystic ovary syndrome: a prospective controlled clinical study","volume":"88","author":"Palomba","year":"2014","journal-title":"Steroids"},{"issue":"8","key":"2020071623083447000_B22","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1210\/jc.2014-1214","article-title":"Low-grade chronic inflammation in pregnant women with polycystic ovary syndrome: a prospective controlled clinical study","volume":"99","author":"Palomba","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071623083447000_B23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.fertnstert.2017.06.015","article-title":"Increased rates of complications in singleton pregnancies of women previously diagnosed with polycystic ovary syndrome predominantly in the hyperandrogenic phenotype","volume":"108","author":"de Wilde","year":"2017","journal-title":"Fertil Steril"},{"issue":"9","key":"2020071623083447000_B24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jclinepi.2006.11.021","article-title":"Probabilistic record linkage is a valid and transparent tool to combine databases without a patient identification number","volume":"60","author":"M\u00e9ray","year":"2007","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2020071623083447000_B25","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2014.08.001","article-title":"Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk","volume":"102","author":"Daan","year":"2014","journal-title":"Fertil Steril"},{"issue":"10","key":"2020071623083447000_B26","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1471-0528.2006.01008.x","article-title":"PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors","volume":"113","author":"Broekmans","year":"2006","journal-title":"BJOG"},{"issue":"3","key":"2020071623083447000_B27","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/humrep\/den433","article-title":"Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria","volume":"24","author":"Goverde","year":"2009","journal-title":"Hum Reprod"},{"issue":"2","key":"2020071623083447000_B28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.preghy.2013.04.006","article-title":"Introduction to ISSHP new classification of preeclampsia","volume":"3","author":"Tranquilli","year":"2013","journal-title":"Pregnancy Hypertens"},{"issue":"12","key":"2020071623083447000_B29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.earlhumdev.2009.09.008","article-title":"New Dutch reference curves for birthweight by gestational age","volume":"85","author":"Visser","year":"2009","journal-title":"Early Hum Dev"},{"issue":"2","key":"2020071623083447000_B30","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"issue":"3","key":"2020071623083447000_B31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpeds.2011.02.017","article-title":"The epidemic of multiple gestations and neonatal intensive care unit use: the cost of irresponsibility","volume":"159","author":"Janvier","year":"2011","journal-title":"J Pediatr"},{"issue":"4","key":"2020071623083447000_B32","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.fertnstert.2012.02.031","article-title":"Ovarian stimulation and intrauterine insemination at the quarter centennial: implications for the multiple births epidemic","volume":"97","author":"McClamrock","year":"2012","journal-title":"Fertil Steril"},{"issue":"3","key":"2020071623083447000_B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6703a1","article-title":"Assisted reproductive technology surveillance - United States, 2015","volume":"67","author":"Sunderam","year":"2018","journal-title":"MMWR Surveill Summ"},{"issue":"12","key":"2020071623083447000_B34","first-page":"2829","article-title":"Placental characteristics in women with polycystic ovary syndrome","volume":"30","author":"Koster","year":"2015","journal-title":"Hum Reprod"},{"issue":"7","key":"2020071623083447000_B35","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1210\/jc.2012-1100","article-title":"Decidual endovascular trophoblast invasion in women with polycystic ovary syndrome: an experimental case-control study","volume":"97","author":"Palomba","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2020071623083447000_B36","doi-asserted-by":"crossref","first-page":"E1373","DOI":"10.1152\/ajpendo.00421.2012","article-title":"Maternal androgen excess reduces placental and fetal weights, increases placental steroidogenesis, and leads to long-term health effects in their female offspring","volume":"303","author":"Sun","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"10","key":"2020071623083447000_B37","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1093\/humrep\/det250","article-title":"Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome","volume":"28","author":"Palomba","year":"2013","journal-title":"Hum Reprod"},{"issue":"3","key":"2020071623083447000_B38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.rbmo.2014.04.010","article-title":"Early trophoblast invasion and placentation in women with different PCOS phenotypes","volume":"29","author":"Palomba","year":"2014","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"2020071623083447000_B39","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1210\/jc.2003-030241","article-title":"Insulin resistance and its potential role in pregnancy-induced hypertension","volume":"88","author":"Seely","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623083447000_B40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1757-2215-3-23","article-title":"Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): relationships with adverse outcomes","volume":"3","author":"Falbo","year":"2010","journal-title":"J Ovarian Res"},{"issue":"8","key":"2020071623083447000_B41","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1089\/jwh.2014.5069","article-title":"Risk prediction for adverse pregnancy outcomes in a Medicaid population","volume":"24","author":"Goyal","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"key":"2020071623083447000_B42","unstructured":"European Commission. European core health indicators. Available at: https:\/\/ec.europa.eu\/health\/indicators_data\/indicators_en. Accessed 27 December 2018."},{"issue":"5","key":"2020071623083447000_B43","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/jch.12957","article-title":"Risk factors for preeclampsia in infertile Chinese women with polycystic ovary syndrome: a prospective cohort study","volume":"19","author":"Xia","year":"2017","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"2020071623083447000_B44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/aogs.12545","article-title":"Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes","volume":"94","author":"Mumm","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"2020071623083447000_B45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/jwh.2014.5000","article-title":"Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study","volume":"24","author":"Joham","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"issue":"2","key":"2020071623083447000_B46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/humrep\/dew287","article-title":"The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria","volume":"32","author":"Wang","year":"2017","journal-title":"Hum Reprod"},{"issue":"2","key":"2020071623083447000_B47","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2020071623083447000_B48","first-page":"CD010443","article-title":"Combined diet and exercise interventions for preventing gestational diabetes mellitus","volume":"11","author":"Shepherd","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2020071623083447000_B49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/1471-0528.14257","article-title":"Obstetric and neonatal complications in pregnancies conceived after oocyte donation: a systematic review and meta-analysis","volume":"124","author":"Storgaard","year":"2017","journal-title":"BJOG"},{"issue":"2","key":"2020071623083447000_B50","doi-asserted-by":"crossref","first-page":"dvy007","DOI":"10.1093\/eep\/dvy007","article-title":"POHaD: why we should study future fathers","volume":"4","author":"Soubry","year":"2018","journal-title":"Environ Epigenet"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/3\/809\/27644257\/jc.2018-01787.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/3\/809\/27644257\/jc.2018-01787.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T11:53:31Z","timestamp":1594986811000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/3\/809\/5257819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,24]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-01787","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2018,12,24]]}}}